Fertility Before TRT

Fertility decisions are easiest to protect before testosterone from a prescription suppresses the reproductive axis. This worksheet defines the goal, records the baseline, and helps decide whether a reproductive specialist belongs in the plan. The summary lines live in the testosterone record (Appendix A).

Define the reproductive goal

• Time horizon: my preferred timeframe for a pregnancy.
• Time pressure: factors that make time important for me or my partner.
• History: prior pregnancies, paternity, or infertility evaluation.
• What might change: life events that could alter my goal.

Prior paternity does not prove current fertility. Uncertainty is a valid answer here.

Document baseline reproductive information

• Semen analysis discussed before treatment: yes or no.
• Result: collection date, laboratory, and the clinician's interpretation.
• Examination: physical or reproductive examination completed.
• Known concerns: varicocele, injury, undescended testis, infection, surgery, or genetic concern.
• Partner or couple evaluation already underway.

One semen sample may not represent usual production, especially when it is abnormal or was collected under unusual conditions. The clinician decides whether repeat testing is needed.

Consider sperm cryopreservation

• Decision: reason to bank now, or reason not to.
• Collections: number recommended by the laboratory.
• Account: contact information and account owner.
• Policies reviewed: fees, renewal, disposition, and contact-update policies.
• Expectations explained: post-thaw expectations and assisted-reproduction uses.

Banking preserves an option; it does not guarantee a pregnancy or improve the stored sample. A decision to decline banking should be recorded without implying that recovery after future suppression is certain.

Understand what prescription testosterone can change

Mark each statement only when it is understood, and ask about any that is not clear before treatment begins.

• Prescription testosterone can raise blood testosterone while lowering LH, FSH, the testosterone inside the testicle, and sperm production.
• A normal or high blood testosterone during treatment does not prove that sperm are present.
• Every standard formulation can suppress fertility, even if the observed degree varies.
• Recovery after stopping is common but variable, and no date can be guaranteed for an individual.
• Hormone recovery and semen recovery can occur on different timelines.
• An abnormal semen result after exposure does not by itself prove permanent infertility.
• Pregnancy and live birth depend on more than one hormone or one partner's semen result.

Compare treatment paths by the fertility goal

This section records a clinician-guided discussion. It does not select a medicine from a worksheet.

• Prescription testosterone discussed, and its expected fertility consequence.
• Treating an underlying contributor first discussed.
• A supervised strategy to support my own signaling discussed, or noted as not biologically appropriate.
• Off-label or unapproved status disclosed where relevant.
• Reproductive urologist or fertility specialist referral discussed.
• Assisted-reproduction options discussed when relevant, or not yet needed.

Plan follow-up around the real endpoint

• Endpoint: the fertility endpoint we will measure, and its baseline.
• Reassessment: clinician-selected date or event for semen reassessment.
• Interpreter: the clinician who will read semen results.
• Escalation trigger: the finding that would prompt specialist referral.
• Contingency: what we do if testosterone improves but semen worsens.
• Path chosen: the treatment path for now, and why.
• Accepted uncertainty: the important uncertainty I accept.

Common questions